Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morag MacLean

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Thorax|November 22, 2019
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)Steve Cunningham, Catriona Graham, Morag MacLean, et al.
Circulation|September 25, 2023
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE TrialPeter A Henriksen, Peter Hall, Iain R MacPherson, et al.
Thorax|October 24, 2017
International management platform for children's interstitial lung disease (chILD-EU)Matthias Griese, Elias Seidl, Meike Hengst, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
JAMA|May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical TrialJannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Thorax|November 22, 2019
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)Steve Cunningham, Catriona Graham, Morag MacLean, et al.
Circulation|September 25, 2023
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE TrialPeter A Henriksen, Peter Hall, Iain R MacPherson, et al.
Thorax|October 24, 2017
International management platform for children's interstitial lung disease (chILD-EU)Matthias Griese, Elias Seidl, Meike Hengst, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
JAMA|May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical TrialJannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Pageof 2